Literature DB >> 3546574

Vaccination-induced variation in the 140 kD merozoite surface antigen of Plasmodium knowlesi malaria.

F W Klotz, D E Hudson, H G Coon, L H Miller.   

Abstract

Immunity to 143/140 kD schizont antigens of a monkey malaria, Plasmodium knowlesi, provides partial protection to lethal malaria infection in rhesus monkeys challenged with uncloned parasites. To determine the capacity of a cloned parasite to generate variants of the 143/140 kD antigens, immunized monkeys were challenged with a clone of P. knowlesi. Parasites recovered 8 d after inoculation with a cloned parasite retained the 143/140 kD antigens. Parasites recovered 30 d after challenge had undergone changes in the 143/140 kD antigens. Antibodies that block erythrocyte invasion in vitro of the inoculum parasites did not inhibit invasion of erythrocytes by two isolates recovered from the immunized monkeys. An isolate from one monkey recovered on day 30 contained clones expressing new 76/72 kD antigens reactive with rabbit antiserum against the 143/140 kD proteins, and other clones expressing no antigens crossreactive with antisera against the 143/140 kD proteins. An isolate from another monkey obtained 59 d after challenge expressed new antigens of 160/155, 115/113, and 87/85 kD. Using monoclonal antibodies, we found that epitopes were lost from the variant proteins, but we were unable to determine whether new epitopes had appeared. We conclude that clones of P. knowlesi can rapidly vary antigenic determinants on the 143/140 kD proteins in animals immunized with these antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546574      PMCID: PMC2188501          DOI: 10.1084/jem.165.2.359

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Gamma-globulin and acquired immunity to human malaria.

Authors:  S COHEN; I A McGREGOR; S CARRINGTON
Journal:  Nature       Date:  1961-11-25       Impact factor: 49.962

2.  Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants.

Authors:  L H Miller; S J Mason; J A Dvorak; M H McGinniss; I K Rothman
Journal:  Science       Date:  1975-08-15       Impact factor: 47.728

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein.

Authors:  P H David; D E Hudson; T J Hadley; F W Klotz; L H Miller
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

5.  Monoclonal antibodies to a 140,000-m.w. protein on Plasmodium knowlesi merozoites inhibit their invasion of rhesus erythrocytes.

Authors:  L H Miller; P H David; D E Hudson; T J Hadley; R L Richards; M Aikawa
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

6.  Identification of surface proteins on viable Plasmodium knowlesi merozoites.

Authors:  J G Johnson; N Epstein; T Shiroishi; L H Miller
Journal:  J Protozool       Date:  1981-05

7.  Action of malarial antibody in vitro.

Authors:  S Cohen; G A Butcher; R B Crandall
Journal:  Nature       Date:  1969-07-26       Impact factor: 49.962

8.  Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors.

Authors:  G H Mitchell; T J Hadley; M H McGinniss; F W Klotz; L H Miller
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

9.  Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria.

Authors:  J W Barnwell; R J Howard; H G Coon; L H Miller
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen.

Authors:  M Hommel; P H David; L D Oligino
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more
  7 in total

1.  Selection for high and low virulence in the malaria parasite Plasmodium chabaudi.

Authors:  M J Mackinnon; A F Read
Journal:  Proc Biol Sci       Date:  1999-04-07       Impact factor: 5.349

Review 2.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Genetic hypervariability of telomere-related sequences is associated with meiosis in Plasmodium falciparum.

Authors:  K D Vernick; D Walliker; T F McCutchan
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

4.  B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.

Authors:  J C Lima-Junior; J Jiang; R N Rodrigues-da-Silva; D M Banic; T M Tran; R Y Ribeiro; V S E Meyer; S G De-Simone; F Santos; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2011-01-06       Impact factor: 3.641

5.  Transfected Plasmodium knowlesi produces bioactive host gamma interferon: a new perspective for modulating immune responses to malaria parasites.

Authors:  Hastings Ozwara; Jan A M Langermans; Clemens H M Kocken; Annemarie van der Wel; Peter H van der Meide; Richard A W Vervenne; Jason M Mwenda; Alan W Thomas
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  Development of the piggyBac transposable system for Plasmodium berghei and its application for random mutagenesis in malaria parasites.

Authors:  Jannik Fonager; Blandine M D Franke-Fayard; John H Adams; Jai Ramesar; Onny Klop; Shahid M Khan; Chris J Janse; Andrew P Waters
Journal:  BMC Genomics       Date:  2011-03-20       Impact factor: 3.969

7.  Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

Authors:  Fiona M Thompson; David W Porter; Shinji L Okitsu; Nicole Westerfeld; Denise Vogel; Stephen Todryk; Ian Poulton; Simon Correa; Claire Hutchings; Tamara Berthoud; Susanna Dunachie; Laura Andrews; Jack L Williams; Robert Sinden; Sarah C Gilbert; Gerd Pluschke; Rinaldo Zurbriggen; Adrian V S Hill
Journal:  PLoS One       Date:  2008-01-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.